Fine Organic Industries Ltd (FINEORG)
🎯 Key Takeaways
- Fine Organic Industries Ltd is in a growth phase driven by expanding export demand and strategic investments, evidenced by consistent top-line growth and margin improvement. Management is executing a capital allocation strategy focused on international expansion and operational scaling, supported by a strong balance sheet and disciplined leverage profile.
- Revenue grew 11% QoQ to ₹694 in Q1FY27.
- ⚠️ Raw material cost inflation and geopolitical disruptions in supply chains are being actively monitored, with management citing elevated costs due to g
- Market Cap
- ₹15,696
- P/E Ratio
- 35.8
- P/B Ratio
- 5.89
- ROE
- 16.4%
- ROCE
- 21.2%
- Debt/Equity
- 0.02
- Div Yield
- 0.21%
- Promoter
- 75.0%
📖 The Story
Fine Organic Industries Ltd is in a growth phase driven by expanding export demand and strategic investments, evidenced by consistent top-line growth and margin improvement. Management is executing a capital allocation strategy focused on international expansion and operational scaling, supported by a strong balance sheet and disciplined leverage profile.
📰 What's Happening
In Q1FY27, revenue surged 18% YoY to ₹694.2 crores, with EBITDA up 42.4% to ₹176 crores and margin expanding to 25.3%, reflecting operational efficiency gains. PAT grew 18% YoY to ₹138.1 crores, and EPS rose to ₹45.06. The company finalized a ₹4.35 crore insurance settlement related to the Badlapur plant incident. Management highlighted stable demand and strong export performance as key growth drivers. Additionally, the Board approved unaudited Q1 results showing consolidated total income of ₹718.42 crores, up 14% YoY, with net profit attributable to shareholders increasing 33% YoY to ₹148.34 crores. Shareholders recently approved a final dividend of ₹11 per share and ratified director appointments and remuneration revisions at the AGM.
Source: Stock Announcements
📊 Quarterly Results (₹ Cr)
| Metric | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | 597 | 555 | 625 | 694 |
| Operating Profit | 122 | 81 | 112 | 162 |
| OPM % | 20.5% | 14.5% | 17.9% | 23.4% |
| Net Profit | 109 | 74 | 117 | 138 |
| EPS | ₹35.40 | ₹24.11 | ₹38.32 | ₹45.06 |
The company has demonstrated accelerating revenue and profit growth over the past four quarters, with revenue rising from ₹555 crores in Dec 2025 to ₹694.2 crores in Jun 2026, and net profit expanding from ₹74 crores to ₹138 crores in the same period. Operating margins improved from 14.5% to 23.4%, indicating operating leverage and cost control. EBITDA growth outpaced revenue growth, signaling margin expansion from scale and operational improvements. This trajectory aligns with management's focus on export-led growth and strategic acquisitions, including the proposed acquisition of Oleofine Organics and establishment of a US subsidiary with $1.12 million investment.
🔮 Management Outlook & What's Next
Management expressed confidence in sustained export momentum and stable demand conditions, while acknowledging ongoing raw material cost pressures and geopolitical risks from West Asia tensions. No formal forward guidance on revenue or margins was provided in the latest filings. However, the company emphasized progress on strategic initiatives, including the US subsidiary setup and the proposed acquisition of Oleofine Organics for ~₹83 crores. The Board also indicated that remuneration revisions for Whole-Time Directors would become effective upon AGM approval, contingent on shareholder voting.
Extracted from official company announcements. Not StockFin.ai's opinion.
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2025 | Mar 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 15 | 15 | 15 | 15 |
| Reserves | 2,280 | 2,105 | 2,649 | 2,462 |
| Borrowings | 3 | 4 | 45 | 16 |
| Total Liabilities | 2,504 | 2,347 | 2,999 | 2,660 |
| Fixed Assets | 361 | 221 | 390 | 371 |
| Investments | 35 | 35 | 38 | 34 |
| Total Assets | 2,504 | 2,347 | 2,999 | 2,660 |
The balance sheet shows a strong equity base of ₹15 crores with reserves growing from ₹2,280 crores in Mar 2025 to ₹2,649 crores in Mar 2026, indicating retained earnings growth. Borrowings remain minimal, declining from ₹3 crores to ₹16 crores in short-term liabilities, reflecting conservative capital structure and low leverage (D/E of 0.02). Total assets have grown steadily from ₹2,504 crores to ₹2,999 crores, supporting expansion without significant debt accumulation. This financial profile suggests prudent capital management and capacity to fund growth internally or through modest debt.
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2026 |
|---|---|
| Operating | +430 |
| Investing | -409 |
| Financing | -0 |
| Net Cash Flow | +20 |
👥 Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 75.0% | 75.0% | 75.0% | 75.0% |
| FII | 4.6% | 4.4% | 4.4% | 4.3% |
| DII | 12.0% | 11.8% | 11.7% | 11.7% |
| Public | 7.1% | 7.4% | 7.5% | 7.6% |
| # Shareholders | 97,992 | 93,942 | 88,948 | 83,591 |
Institutional investor interest has remained stable, with FII holdings holding steady at 4.28% in Q1FY27 compared to 4.57% in Q2FY26, while DII holdings declined slightly from 12.02% to 11.72% over the same period. Promoter holding remains unchanged at 75%. The number of public shareholders has increased from 88,948 to 83,591 across quarters, suggesting broadening retail interest. No significant changes in shareholding patterns indicate stable investor confidence, with no signs of large-scale exits or accumulations in recent quarters.
⚖️ Peer Comparison — Chemicals
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| PIDILITIND | 1.53 L Cr | 57.6 | 33.4% | — | 0.01 |
| SRF | 73,810 | 34.1 | 15.6% | — | 0.36 |
| LINDEINDIA | 52,814 | 96.7 | 17.5% | — | 0.00 |
| FLUOROCHEM | 48,774 | 79.7 | 9.6% | — | 0.34 |
| NAVINFLUOR | 43,256 | 54.7 | 22.2% | — | 0.31 |
| GODREJIND | 36,153 | 30.8 | 9.2% | — | 4.57 |
| HSCL | 33,807 | 42.0 | 20.7% | — | 0.16 |
| AETHER | 23,029 | 97.7 | 13.8% | — | 0.08 |
| DEEPAKNTR | 21,155 | 27.0 | 15.3% | — | 0.26 |
| CASTROLIND | 19,891 | 18.7 | 76.2% | — | 0.00 |
🔗 Peer Stock Analyses
⚠️ Risk Factors
1. Raw material cost inflation and geopolitical disruptions in supply chains are being actively monitored, with management citing elevated costs due to global tensions. 2. Integration risks associated with the proposed acquisition of Oleofine Organics and expansion into the US market could impact execution and profitability. 3. Regulatory and compliance costs, including labor code updates and gratuity provisions, have already increased provisions by ₹7.11 crores, potentially affecting margins. 4. Despite strong growth, the company operates in a cyclical chemicals sector where export demand can be volatile due to global economic conditions.
📋 Recent Filings
- Announcement2026-09-28Fine Organic Industries Ltd announced a trading window closure effective October 1, 2026, until unaudited quarterly results are released and 48 hours …
- 🔴 Announcement2026-09-16Fine Organic Industries Ltd announced its participation in an investor conference on September 29, 2026, hosted by PL Capital, with a scheduled meetin…
- 🔴 Announcement2026-09-15Fine Organic Industries Ltd announced its participation in an investor conference on September 21, 2026, organized by Anand Rathi, featuring one-on-on…
- 🔴 Corporate Action2026-09-09Fine Organic Industries announced completion of its acquisition of an 80% stake in Oleofine Organics Sdn. BHD. (OFM) on September 9, 2026, making OFM …
- 🔴 Corporate Action2026-09-02Fine Organic Industries announced on September 2, 2026 that it has executed share transfer agreements to acquire an 80% stake in Oleofine Organics SDN…
- Announcement2026-08-18Fine Organic Industries Limited announced an extension of the timeline for completing its acquisition of 80% of Oleofine Organics SDN. BHD., pushing c…
- 🟡 Board Meeting2026-08-18At the 24th AGM on August 18, 2026, shareholders approved all eight resolutions including a final dividend of **[amount context mismatch] per share**,…
- Announcement2026-08-10Fine Organic Industries Limited presented its August 2026 investor deck highlighting its global leadership in green oleochemical additives, diversifie…
- 🔴 Financial Results2026-08-10Fine Organic Industries reported consolidated revenue of **₹694.2 crores** for Q1FY27, up **18% YoY** from ₹588.4 crores in Q1FY26, driven by stable d…
- 🟡 Board Meeting2026-08-07The Board of Fine Organic Industries Limited approved the unaudited standalone and consolidated financial results for Q1 June 2026 during its meeting …
🧠 Analyst's Read
Fine Organic Industries is executing a clear growth strategy supported by solid financial performance, margin expansion, and low leverage, but faces execution risks in its international expansion and exposure to global commodity and geopolitical headwinds. Investors should monitor the progress of the Oleofine Organics acquisition and US subsidiary operations for signs of contribution to future growth.
Based on filing content and financial data. Not a recommendation.
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-29.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when FINEORG files new disclosures
Track FINEORG filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track FINEORG — FreeFree account · 2 AI queries/day